Filing Details
- Accession Number:
- 0001225208-15-019953
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-10-28 16:02:41
- Reporting Period:
- 2015-10-27
- Filing Date:
- 2015-10-28
- Accepted Time:
- 2015-10-28 16:02:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 9892 | Bard C R Inc | BCR | Surgical & Medical Instruments & Apparatus (3841) | 221454160 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1297506 | K Gail Naughton | C/O C. R. Bard, Inc. 730 Central Avenue Murray Hill NJ 07974 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-10-27 | 1,200 | $88.76 | 3,214 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-10-27 | 800 | $81.70 | 4,014 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-10-27 | 2,458 | $181.99 | 1,556 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option (Right to Buy) | Disposition | 2015-10-27 | 1,200 | $0.00 | 1,200 | $88.76 |
| Common Stock | Option (Right to Buy) | Disposition | 2015-10-27 | 800 | $0.00 | 800 | $81.70 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2018-07-09 | No | 4 | M | Direct | |
| 0 | 2019-12-09 | No | 4 | M | Direct |
Footnotes
- Includes 6.0564 shares acquired under the Company's Dividend Reinvestment Plan from February 7, 2015 to July 31, 2015.
- Represents the weighted average sales price for price increments ranging from $181.83 to $182.67. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Award/Grant pursuant to the 2005 Directors' Stock Award Plan, as amended and restated.
- Options vested in three equal annual installments beginning on July 9, 2009 and are currently exercisable.
- Options vested in three equal annual installments beginning on December 9, 2010 and are currently exercisable.
Billionaire Hedge Funds
